The lambeth conventions (II): Guidelines for the study of animal and human ventricular and supraventricular arrhythmias

Pharmacology and Therapeutics

Volumn 139, Issue 2, 2013, Pages 213-248

  Curtis, Michael J ^a   Hancox, Jules C ^b   Farkas, András ^c   Wainwright, Cherry L ^d   Stables, Catherine L ^e   Saint, David A ^f   Clements Jewery, Hugh ^g   Lambiase, Pier D ^h   Billman, George E ⁱ   Janse, Michiel J ^j   Pugsley, Michael K ^k   Ng, G André ^l   Roden, Dan M ^m   Camm, A John ⁿ   Walker, Michael J A ^o  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

^c UNIVERSITY OF SZEGED   (Hungary)

^d ROBERT GORDON UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF ADELAIDE   (Australia)

^g WEST VIRGINIA SCHOOL OF OSTEOPATHIC MEDICINE   (United States)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ OHIO STATE UNIVERSITY   (United States)

^j UNIVERSITY OF AMSTERDAM   (Netherlands)

^k Johnson and Johnson PRD OMP 2357 ^*  (United States)

^l UNIVERSITY OF LEICESTER   (United Kingdom)

^m VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^o UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

Antiarrhythmic; Lambeth Conventions; Methods; Supraventricular arrhythmia; Torsades de pointes; Ventricular arrhythmia

Indexed keywords

ANTIARRHYTHMIC AGENT;

ARRHYTHMOGENESIS; CLINICAL RESEARCH; DIASTOLIC BLOOD PRESSURE; DRUG INDUCED ARRHYTHMIA; DRUG INDUCED DISEASE; ELECTROCARDIOGRAPHY; FOURIER TRANSFORMATION; GENETIC DISORDER; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HERITABLE ARRHYTHMIA; HUMAN; ISCHEMIA; NONHUMAN; OSCILLOMETRY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; VALIDITY;

ANIMALS; ARRHYTHMIAS, CARDIAC; BIOMEDICAL RESEARCH; HUMANS; RESEARCH DESIGN;

EID: 84879409719     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2013.04.008     Document Type: Review

References (327)

1. H.S. Abed, C.S. Samuel, D.H. Lau, D.J. Kelly, S.G. Royce, and M. Alasady Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation Heart Rhythm 10 2013 90 100
2. N. Abi-Gerges, K. Philp, C. Pollard, I. Wakefield, T.G. Hammond, and J.P. Valentin Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes Fundam Clin Pharmacol 18 2004 139 151
3. F.G. Akar, K.R. Laurita, and D.S. Rosenbaum Cellular basis for dispersion of repolarization underlying reentrant arrhythmias J Electrocardiol 33 2000 23 31 (Suppl.)
4. F.G. Akar, G.X. Yan, C. Antzelevitch, and D.S. Rosenbaum Unique topographical distribution of M cells underlies reentrant mechanism of Torsade de Pointes in the long-QT syndrome Circulation 105 2002 1247 1253
5. A. Allessie, M. Avkiran, M. Borggrefe, E. Carmeliet, S.M. Cobbe, and S. Dhein The role of basic arrhythmia research. The continued need for experiments in the intact heart and organism Eur Heart J 16 1995 1469 1475
6. B. Altshuler Modeling of dose-response relationships Environ Health Perspect 42 1981 23 27
7. R.A. Alyea, N.P. Moore, M.J. LeBaron, B.B. Gollapudi, and R.J. Rasoulpour Is the current product safety assessment paradigm protective for epigenetic mechanisms? J Pharmacol Toxicol Methods 66 2012 207 214
8. I.S. Anand, and V.G. Florea End points in chronic heart failure clinical trials Dialog Cardiovasc Med 15 2010 81 101
9. P.A. Anderson, J.S. Rankin, C.E. Arentzen, R.W. Anderson, and E.A. Johnson Evaluation of the force-frequency relationship as a descriptor of the inotropic state of canine left ventricular myocardium Circ Res 39 1976 832 839
10. W. Anne, R. Willems, P. Holemans, F. Beckers, T. Roskams, and I. Lenaerts Self-terminating AF depends on electrical remodeling while persistent AF depends on additional structural changes in a rapid atrially paced sheep model J Mol Cell Cardiol 43 2007 148 158
11. C. Antzelevitch Transmural dispersion of repolarization and the T wave Cardiovasc Res 50 2001 426 431
12. C. Antzelevitch Drug-induced spatial dispersion of repolarization Cardiol J 15 2008 100 121
13. C. Antzelevitch Drug-induced channelopathies D.P. Zipes, J. Jalife, Cardiac Electrophysiology: From Cell to Bedside 5th ed. 2009 W. B. Saunders Co. Philadelphia 195 203
14. E.P. Anyukhovsky, E.A. Sosunov, R.Z. Gainullin, and M.R. Rosen The controversial M cell J Cardiovasc Electrophysiol 10 1999 244 260
15. T.M. Argentieri, M.S. Carroll, and M.E. Sullivan Cellular electrophysiological effects of the class III antiarrhythmic agents sematilide and clofilium on rabbit atrial tissues J Cardiovasc Pharmacol 18 1991 167 174
16. T.L. Au, G.A. Collins, B.A. Macleod, and M.J. Walker Effects of prostaglandin E2, propranolol and nitroglycerine with halothane, pethidine or pentobarbitone anaesthesia on arrhythmias and other responses to ligation of a coronary artery in rats Br J Pharmacol 79 1983 929 937
17. S. Authier, M.K. Pugsley, E. Troncy, and M.J. Curtis Arrhythmogenic liability screening in cardiovascular safety pharmacology: commonality between non-clinical safety pharmacology and clinical thorough QT (TQT) studies J Pharmacol Toxicol Methods 62 2010 83 88
18. T. Azar, J. Sharp, and D. Lawson Heart rates of male and female Sprague-Dawley and spontaneously hypertensive rats housed singly or in groups J Am Assoc Lab Anim Sci 50 2011 175 184
19. + current by overexpression of the long-QT syndrome HERG G628S mutation in transgenic mice Circ Res 83 1998 668 678
20. I. Baczkó, I. Leprán, and J.G. Papp Influence of anesthetics on the incidence of reperfusion-induced arrhythmias and sudden death in rats J Cardiovasc Pharmacol 29 1997 196 201
21. A.J. Batey, and S.J. Coker Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of Torsade de Pointes Br J Pharmacol 135 2002 1003 1012
22. K.A. Bayne Environmental enrichment of nonhuman primates, dogs and rabbits used in toxicology studies Toxicol Pathol 31 2003 132 137 (Suppl.)
23. J.L. Bergey, K. Nocella, and J.D. McCallum Acute coronary artery occlusion-reperfusion-induced arrhythmias in rats, dogs and pigs: antiarrhythmic evaluation of quinidine, procainamide and lidocaine Eur J Pharmacol 81 1982 205 216
24. M. Bernier, M.J. Curtis, and D.J. Hearse Ischemia-induced and reperfusion-induced arrhythmias: importance of heart rate Am J Physiol 256 1989 H21 H31
25. C.I. Berul, M.J. Aronovitz, P.J. Wang, and M.E. Mendelsohn In vivo cardiac electrophysiology studies in the mouse Circulation 94 1996 2641 2648
26. J.T. Bigger Jr., and F.M. Weld Analysis of prognostic significance of ventricular arrhythmias after myocardial infarction. Shortcomings of Lown grading system Br Heart J 45 1981 717 724
27. G.E. Billman Animal models of lethal arrhythmias Drug Dev Res 55 2002 59 72
28. G.E. Billman A comprehensive review and analysis of 25 years of data from an in vivo canine model of sudden cardiac death: implications for future anti-arrhythmic drug development Pharmacol Ther 111 2006 808 835
29. G.E. Billman Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: effect of endurance exercise training Am J Physiol Heart Circ Physiol 297 2009 H1171 H1193
30. P.E. Bloch Thomsen, C. Jons, M.J. Raatikainen, R. Moerch Joergensen, J. Hartikainen, and V. Virtanen Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study Circulation 122 2010 1258 1264
31. M. Bohm, N. Roewer, W. Schmitz, H. Scholz, and J. Schulte am Esch Effects of beta- and alpha-adrenergic agonists, adenosine, and carbachol in heart muscle isolated from malignant hyperthermia susceptible swine Anesthesiology 68 1988 38 43
32. R. Bolli, D.J. Fisher, and M.L. Entman Factors that determine the occurrence of arrhythmias during acute myocardial ischemia Am Heart J 111 1986 261 270
33. R. Bolli, M.L. Myers, W.X. Zhu, and R. Roberts Disparity of reperfusion arrhythmias after reversible myocardial ischemia in open chest and conscious dogs J Am Coll Cardiol 7 1986 1047 1056
34. J.H. Botting, M.J. Curtis, and M.J. Walker Arrhythmias associated with myocardial ischaemia and infarction Mol Aspects Med 8 1985 307 422
35. B.J. Boukens, M.G. Hoogendijk, A.O. Verkerk, A. Linnenbank, P. van Dam, and C.A. Remme Early repolarization in mice causes overestimation of ventricular activation time by the QRS duration Cardiovasc Res 97 2013 182 191
36. R. Breckenridge Heart failure and mouse models Dis Model Mech 3 2010 138 143
37. A. Bril, M.C. Forest, and B. Gout Ischemia and reperfusion-induced arrhythmias in rabbits with chronic heart failure Am J Physiol 261 1991 H301 H307
38. J. Brouillette, K. Rivard, E. Lizotte, and C. Fiset Sex and strain differences in adult mouse cardiac repolarization: importance of androgens Cardiovasc Res 65 2005 148 157
39. M. Brunner, X. Peng, G.X. Liu, X.Q. Ren, O. Ziv, and B.R. Choi Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome J Clin Invest 118 2008 2246 2259
40. D.J. Callans, D. Schwartzman, C.D. Gottlieb, and F.E. Marchlinski Insights into the electrophysiology of atrial arrhythmias gained by the catheter ablation experience: "learning while burning, Part II" J Cardiovasc Electrophysiol 6 1995 229 243
41. X. Cao, Y.T. Lee, M. Holmqvist, Y. Lin, Y. Ni, and D. Mikhailov Cardiac ion channel safety profiling on the IonWorks Quattro automated patch clamp system Assay Drug Dev Technol 8 2010 766 780
42. B.A. Carabello Modern management of mitral stenosis Circulation 112 2005 432 437
43. L. Carlsson The anaesthetised methoxamine-sensitised rabbit model of Torsades de Pointes Pharmacol Ther 119 2008 160 167
44. L. Carlsson, O. Almgren, and G. Duker QTU-prolongation and Torsades de Pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions J Cardiovasc Pharmacol 16 1990 276 285
45. M.C. Casimiro, B.C. Knollmann, S.N. Ebert, J.C. Vary Jr., A.E. Greene, and M.R. Franz Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen Syndrome Proc Natl Acad Sci USA 98 2001 2526 2531
46. C.Y. Chai, T.F. Huang, and S.C. Wang Mechanisms of cardiac arrhythmias induced by baroceptor reflexes in cats Am J Physiol 215 1968 1316 1323
47. F. Charpentier, A. Bourge, and J. Merot Mouse models of SCN5A-related cardiac arrhythmias Prog Biophys Mol Biol 98 2008 230 237
48. F.I. Chaudhry, S.C. Dennis, and J.B. Harness Spectral analysis of electrocardiogram signals of the isolated guinea pig heart for the detection of arrhythmias J Biomed Eng 4 1982 289 293
49. Y.J. Chen, S.A. Chen, M.S. Chang, and C.I. Lin Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation Cardiovasc Res 48 2000 265 273
50. P.S. Chen, and A.Y. Tan Autonomic nerve activity and atrial fibrillation Heart Rhythm 4 2007 S61 S64
51. H.C. Cheng, and J. Incardona Models of Torsades de Pointes: effects of FPL64176, DPI201106, dofetilide, and chromanol 293B in isolated rabbit and guinea pig hearts J Pharmacol Toxicol Methods 60 2009 174 184
52. J. Chiladakis, A. Kalogeropoulos, P. Arvanitis, N. Koutsogiannis, F. Zagli, and D. Alexopoulos Preferred QT correction formula for the assessment of drug-induced QT interval prolongation J Cardiovasc Electrophysiol 21 2010 905 913
53. S. Chlopcikova, J. Psotova, and P. Miketova Neonatal rat cardiomyocytes - a model for the study of morphological, biochemical and electrophysiological characteristics of the heart Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 145 2001 49 55
54. B.R. Choi, and G. Salama Simultaneous maps of optical action potentials and calcium transients in guinea-pig hearts: mechanisms underlying concordant alternans J Physiol 529 Pt 1 2000 171 188
55. R.H. Clayton, A. Murray, P.D. Higham, and R.W.F. Campbell Self-terminating ventricular tachyarrhythmias - a diagnostic dilemma? Lancet 341 1993 93 95
56. H. Clements-Jewery, D.J. Hearse, and M.J. Curtis Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation Br J Pharmacol 145 2005 551 564
57. S.J. Coker, and J.R. Parratt Relationships between the severity of myocardial ischaemia, reperfusion-induced ventricular fibrillation, and the late administration of dazmegrel or nifedipine J Cardiovasc Pharmacol 7 1985 327 334
58. S.J. Connolly Use and misuse of surrogate outcomes in arrhythmia trials Circulation 113 2006 764 766
59. A.R. Cook, S.C. Bardswell, S. Pretheshan, K. Dighe, G.S. Kanaganayagam, and R.I. Jabr Paradoxical resistance to myocardial ischemia and age-related cardiomyopathy in NHE1 transgenic mice: a role for ER stress? J Mol Cell Cardiol 46 2009 225 233
60. R. Coronel, F.J. Wilms-Schopman, and J.R. deGroot Origin of ischemia-induced phase 1b ventricular arrhythmias in pig hearts J Am Coll Cardiol 39 2002 166 176
61. D. Corradi, S. Callegari, R. Maestri, D. Ferrara, D. Mangieri, and R. Alinovi Differential structural remodeling of the left-atrial posterior wall in patients affected by mitral regurgitation with or without persistent atrial fibrillation: a morphological and molecular study J Cardiovasc Electrophysiol 23 2012 271 279
62. F.G. Cosio, A. Martin-Penato, A. Pastor, A. Nunez, and A. Goicolea Atypical flutter: a review Pacing Clin Electrophysiol 26 2003 2157 2169
63. M.J. Curtis Torsades de Pointes: arrhythmia, syndrome, or chimera? A perspective in the light of the Lambeth Conventions Cardiovasc Drugs Ther 5 1991 191 200
64. M.J. Curtis Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischaemia-induced ventricular fibrillation Cardiovasc Res 39 1998 194 215
65. M.J. Curtis, and D.J. Hearse Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation J Mol Cell Cardiol 21 1989 21 40
66. M.J. Curtis, and D.J. Hearse Reperfusion-induced arrhythmias are critically dependent upon occluded zone size: relevance to the mechanism of arrhythmogenesis J Mol Cell Cardiol 21 1989 625 637
67. M.J. Curtis, K.M. Johnston, and M.J.A. Walker Arrhythmias and serum potassium during myocardial ischaemia Med Sci Res 13 1985 688 689
68. M.J. Curtis, B.A. Macleod, and M.J. Walker The effects of ablations in the central nervous system on arrhythmias induced by coronary occlusion in the rat Br J Pharmacol 86 1985 663 670
69. M.J. Curtis, B.A. Macleod, and M.J. Walker Models for the study of arrhythmias in myocardial ischaemia and infarction: the use of the rat J Mol Cell Cardiol 19 1987 399 419
70. M.J. Curtis, and M.K. Pugsley Attrition in the drug discovery process: lessons to be learned from the safety pharmacology paradigm Expert Rev Clin Pharmacol 5 2012 237 240
71. M.J. Curtis, and M.J. Walker Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia Cardiovasc Res 22 1988 656 665
72. A.R. Cushny, and C.W. Edmunds Paroxysmal irregularity of the heart and auricular fibrillation Am J Med Sci 133 1907 66 77
73. P. Daleau Effects of antiarrhythmic agents on junctional resistance of guinea pig ventricular cell pairs J Pharmacol Exp Ther 284 1998 1174 1179
74. M.C. Daniels, T. Kieser, and H.E. ter Keurs Triggered propagated contractions in human atrial trabeculae Cardiovasc Res 27 1993 1831 1835
75. M.C. Daniels, and H.E. ter Keurs Spontaneous contractions in rat cardiac trabeculae. Trigger mechanism and propagation velocity J Gen Physiol 95 1990 1123 1137
76. B. Darpo The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance Br J Pharmacol 159 2010 49 57
77. H.T. Davis, J. DeCamilla, L.W. Bayer, and A.J. Moss Survivorship patterns in the posthospital phase of myocardial infarction Circulation 60 1979 1252 1258
78. J. de Bono Propofol: a safe drug for physician-led procedures? Europace 14 2012 303 305
79. W.C. De Mello Cell swelling impairs dye coupling in adult rat ventricular myocytes. Cell volume as a regulator of cell communication Mol Cell Biochem 343 2010 107 113
80. P.C. Deedwania, and J.A. Lardizabal Atrial fibrillation in heart failure: a comprehensive review Am J Med 123 2010 198 204
81. R.L. DeHaan, and R. Hirakow Synchronizatin of pulsation rates in isolated cardiac myocytes Exp Cell Res 70 1972 214 220
82. A.R. Denniss, D.A. Richards, A.T. Taylor, and J.B. Uther Halothane anesthesia reduces inducibility of ventricular tachyarrhythmias in chronic canine myocardial infarction Basic Res Cardiol 84 1989 5 12
83. F. Dessertenne La tachycardie ventriculaire à deux foyers opposés variables Arch Mal Coeur Vaiss 59 1966 263 272
84. J.A. Dixon, and F.G. Spinale Large animal models of heart failure: a critical link in the translation of basic science to clinical practice Circ Heart Fail 2 2009 262 271
85. S.A. Doggrell, and L. Brown Rat models of hypertension, cardiac hypertrophy and failure Cardiovasc Res 39 1998 89 105
86. B.J. Drew, M.J. Ackerman, M. Funk, W.B. Gibler, P. Kligfield, and V. Menon Prevention of Torsade de Pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation J Am Coll Cardiol 55 2010 934 947
87. S. Dubi, and Y. Arbel Large animal models for diastolic dysfunction and diastolic heart failure - a review of the literature Cardiovasc Pathol 19 2010 147 152
88. B. Egner Blood pressure measurement. Basic principles and practical application B. Egner, A.P. Carr, S.A. Brown, Essential Facts of Blood Pressure in Dogs and Cats 2007 Vet Verlag Babenhausen 1 14
89. W. Einthoven Le telecardiogramme Arch Int Physiol 4 1906 132 164
90. S.J. Evans, G.R. Dalton, and A.J. Levi Experimental studies on myocardial stretch and ventricular arrhythmia in hypertrophied and non-hypertrophied hearts J Cardiovasc Risk 7 2000 163 175
91. T.H. t Everett, and J.E. Olgin Atrial fibrosis and the mechanisms of atrial fibrillation Heart Rhythm 4 2007 S24 S27
92. F. Extramiana, and C. Antzelevitch Amplified transmural dispersion of repolarization as the basis for arrhythmogenesis in a canine ventricular-wedge model of short-QT syndrome Circulation 110 2004 3661 3666
93. A. Farkas, and M.J. Curtis Does QT widening in the Langendorff-perfused rat heart represent the effect of repolarization delay or conduction slowing? J Cardiovasc Pharmacol 42 2003 612 621
94. A. Farkas, J. Dempster, and S.J. Coker Importance of vagally mediated bradycardia for the induction of torsade de pointes in an in vivo model Br J Pharmacol 154 2008 958 970
95. A. Farkas, I. Leprán, and J.G. Papp Comparison of the antiarrhythmic and the proarrhythmic effect of almokalant in anaesthetised rabbits Eur J Pharmacol 346 1998 245 253
96. L) in the genesis of dofetilide-induced torsades de pointes in isolated, AV-blocked rabbit hearts Br J Pharmacol 156 2009 920 932
97. A.S. Farkas, and S. Nattel Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice Drugs 70 2010 573 603
98. A.S. Farkas, L. Rudas, P. Makra, N. Csík, I. Leprán, and T. Forster Biomarkers and endogenous determinants of dofetilide-induced torsades de pointes in alpha(1)-adrenoceptor-stimulated, anaesthetized rabbits Br J Pharmacol 161 2010 1477 1495
99. V.B. Fiedler Reduction of myocardial infarction and dysrhythmic activity by nafazatrom in the conscious rat Eur J Pharmacol 88 1983 263 267
100. R.A. Fisher The arrangement of field experiments J Min Agri GB 33 1926 700 725
101. +, pH, and activation in the pig Circulation 72 1985 922 932
102. L.M. Friedman, C.D. Furberg, and D.L. DeMets Fundamentals of Clinical Trials 4th ed. 2010 Springer New York
103. L. Fu, J.X. Cao, R.S. Xie, J. Li, Y. Han, and L.Q. Zhu The effect of streptomycin on stretch-induced electrophysiological changes of isolated acute myocardial infarcted hearts in rats Europace 9 2007 578 584
104. L.I. Ganz, and P.L. Friedman Supraventricular tachycardia N Engl J Med 332 1995 162 173
105. J.J. Garamella, L.J. Hay, and J.G. Andersen Studies in ventricular fibrillation in the pig: evaluation of an antifibrillatory agent tested by closed chest coronary artery occlusion Surg Forum 7 1957 298 301
106. Z.M. Gertz, A. Raina, S.E. Mountantonakis, E.S. Zado, D.J. Callans, and F.E. Marchlinski The impact of mitral regurgitation on patients undergoing catheter ablation of atrial fibrillation Europace 13 2011 1127 1132
107. G.A. Gintant Preclinical Torsades-de-Pointes screens: advantages and limitations of surrogate and direct approaches in evaluating proarrhythmic risk Pharmacol Ther 119 2008 199 209
108. S. Gojraty, N. Lavi, E. Valles, S.J. Kim, J. Michele, and E.P. Gerstenfeld Dominant frequency mapping of atrial fibrillation: comparison of contact and noncontact approaches J Cardiovasc Electrophysiol 20 2009 997 1004
109. A.L. Goldberger, L.A. Amaral, L. Glass, J.M. Hausdorff, P.C. Ivanov, and R.G. Mark PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals Circulation 101 2000 E215 E220
110. R.P. Gould, and T. Powell Intact isolated muscle cells from the adult rat heart J Physiol 225 1972 16P 19P
111. F. Grigioni, J.F. Avierinos, L.H. Ling, C.G. Scott, K.R. Bailey, and A.J. Tajik Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome J Am Coll Cardiol 40 2002 84 92
112. D.S. Grosso, C.J. Frangakis, E.C. Carlson, and R. Bressler Isolation and characterization of myocytes from the adult rat heart Prep Biochem 7 1977 383 401
113. P.J. Guns, D.M. Johnson, E. Weltens, and J. Lissens Negative electro-mechanical windows are required for drug-induced Torsades de Pointes in the anesthetized guinea pig J Pharmacol Toxicol Methods 66 2012 125 134
114. A. Gupta, A.T. Lawrence, K. Krishnan, C.J. Kavinsky, and R.G. Trohman Current concepts in the mechanisms and management of drug-induced QT prolongation and Torsade de Pointes Am Heart J 153 2007 891 899
115. I. Hacking A universe of chance The Taming of Chance 1990 Cambridge University Press Cambridge 200 215
116. R.L. Hamlin Animal models of ventricular arrhythmias Pharmacol Ther 113 2007 276 295
117. R.L. Hamlin, C.A. Cruze, S.W. Mittelstadt, A. Kijtawornrat, B.W. Keene, and B.M. Roche Sensitivity and specificity of isolated perfused guinea pig heart to test for drug-induced lengthening of QTc J Pharmacol Toxicol Methods 49 2004 15 23
118. R.L. Hamlin, and C. Del Rio An approach to the assessment of drug-induced changes in non-electrophysiological properties of cardiovascular function J Pharmacol Toxicol Methods 62 2010 20 29
119. J.C. Hancox, and M.J. Curtis Preparation, preparation, preparation: the influence of adrenergic agonism in cardiac ventricular repolarisation assays used in preclinical drug development and drug safety pharmacology J Pharmacol Toxicol Methods 51 2005 77 79
120. J.C. Hancox, and M.J. Curtis Methods for screening drugs for their pro-arrhythmic liability: does the rabbit ventricular wedge hold the key? J Pharmacol Toxicol Methods 54 2006 257 260
121. J.C. Hancox, M.J. McPate, A. El Harchi, and Y.H. Zhang The hERG potassium channel and hERG screening for drug-induced Torsades de Pointes Pharmacol Ther 119 2008 118 132
122. N. Harris, K.A. Kane, A.W. Muir, and E. Winslow Influences of hypothermia, cold, and isolation stress on the severity of coronary artery ligation-induced arrhythmias in rats J Pharmacol Methods 7 1982 161 171
123. D.W. Harron, M. Brezina, C. Lillie, and W. Kobinger Antifibrillatory properties of alinidine after coronary artery occlusion in rats Eur J Pharmacol 110 1985 301 308
124. J.M. Hartog, J.M. Lamers, and P.D. Verdouw The effects of dietary mackerel oil on plasma and cell membrane lipids, on hemodynamics and cardiac arrhythmias during recurrent acute ischemia in the pig Basic Res Cardiol 81 1986 567 580
125. G. Hasenfuss Animal models of human cardiovascular disease, heart failure and hypertrophy Cardiovasc Res 39 1998 60 76
126. K. Hashimoto Torsades de Pointes liability inter-model comparisons: the experience of the QT PRODACT initiative Pharmacol Ther 119 2008 195 198
127. E. Hayes, M.K. Pugsley, W.P. Penz, G. Adaikan, and M.J. Walker Relationship between QaT and RR intervals in rats, guinea pigs, rabbits, and primates J Pharmacol Toxicol Methods 32 1994 201 207
128. D.J. Hearse, A.S. Manning, and M.J. Janse Life-threatening Arrhythmias During Ischemia and Infarction 1987 Raven Press New York
129. J. Heeringa, D.A. van der Kuip, A. Hofman, J.A. Kors, G. van Herpen, and B.H. Stricker Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study Eur Heart J 27 2006 949 953
130. L.M. Hondeghem Antiarrhythmic agents: modulated receptor applications Circulation 75 1987 514 520
131. L.M. Hondeghem Relative contributions of TRIaD and QT to proarrhythmia J Cardiovasc Electrophysiol 18 2007 655 657
132. L.M. Hondeghem Use and abuse of QT and TRIaD in cardiac safety research: importance of study design and conduct Eur J Pharmacol 584 2008 1 9
133. L.M. Hondeghem, L. Carlsson, and G. Duker Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic Circulation 103 2001 2004 2013
134. R.P. Houben, N.M. de Groot, and M.A. Allessie Analysis of fractionated atrial fibrillation electrograms by wavelet decomposition IEEE Trans Biomed Eng 57 2010 1388 1398
135. E. Hutchinson, A. Avery, and S. Vandewoude Environmental enrichment for laboratory rodents ILAR J 46 2005 148 161
136. + currents in fetal, neonatal, and adult rabbit ventricular myocytes Circ Res 70 1992 508 515
137. ICH E 10 Choice of Control Group and Related Issues in Clinical Trials 2001 (In.)
138. ICH Topic S 7 B Guideline (Step 5 Version): The Nonclinical Evaluation of the Potential for delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals 2005 (In.)
139. S. Imamura, H. Hashimoto, K. Ikeda, and M. Nakashima Effects of volatile anesthetics, enflurane, isoflurane, and halothane on ventricular delayed activation in a canine myocardial infarction model J Electrocardiol 27 1994 41 48
140. H. Inaba, N. Hayami, K. Ajiki, T. Kunishima, H. Watanabe, and K. Tsutsui Deep anesthesia suppresses ventricular tachyarrhythmias in rabbit model of the acquired long QT syndrome Circ J 75 2011 89 93
141. A.F. James, S.C. Choisy, and J.C. Hancox Recent advances in understanding sex differences in cardiac repolarization Prog Biophys Mol Biol 94 2007 265 319
142. T.L. Jang, B.A. MacLeod, and M.J. Walker Effects of halogenated hydrocarbon anesthetics on responses to ligation of a coronary artery in chronically prepared rats Anesthesiology 59 1983 309 315
143. M.J. Janse Focus, reentry, or "focal" reentry? Am J Physiol Heart Circ Physiol 292 2007 H2561 H2562
144. M.J. Janse, R. Coronel, T. Opthof, E.A. Sosunov, E.P. Anyukhovsky, and M.R. Rosen Repolarization gradients in the intact heart: transmural or apico-basal? Prog Biophys Mol Biol 109 2012 6 15
145. M.J. Janse, T. Opthof, and A.G. Kleber Animal models of cardiac arrhythmias Cardiovasc Res 39 1998 165 177
146. M.J. Janse, E.A. Sosunov, R. Coronel, T. Opthof, E.P. Anyukhovsky, and J.M. de Bakker Repolarization gradients in the canine left ventricle before and after induction of short-term cardiac memory Circulation 112 2005 1711 1718
147. M.J. Janse, J.T. Vermeulen, T. Opthof, R. Coronel, F.J. Wilms-Schopman, and H.M. Rademaker Arrhythmogenesis in heart failure J Cardiovasc Electrophysiol 12 2001 496 499
148. B. John, M.K. Stiles, P. Kuklik, S.T. Chandy, G.D. Young, and L. Mackenzie Electrical remodelling of the left and right atria due to rheumatic mitral stenosis Eur Heart J 29 2008 2234 2243
149. K.M. Johnston, B.A. MacLeod, and M.J. Walker Responses to ligation of a coronary artery in conscious rats and the actions of antiarrhythmics Can J Physiol Pharmacol 61 1983 1340 1353
150. W.A. Jolly, and T.W. Ritchie Auricular flutter and fibrillation Heart 3 1911 177 221
151. H.J. Jongsma, M. Masson-Pevet, and L. Tsjernina The development of beat-rate synchronization of rat myocyte pairs in cell culture Basic Res Cardiol 82 1987 454 464
152. Ks in human ventricular muscle Circulation 112 2005 1392 1399
153. J.M. Kalman, J.E. Olgin, L.A. Saxon, W.G. Fisher, R.J. Lee, and M.D. Lesh Activation and entrainment mapping defines the tricuspid annulus as the anterior barrier in typical atrial flutter Circulation 94 1996 398 406
154. W.B. Kannel, D.R. Gagnon, and L.A. Cupples Epidemiology of sudden coronary death: population at risk Can J Cardiol 6 1990 439 444
155. E.S. Kaufman Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome Heart Rhythm 6 2009 S51 S55
156. S. Kettlewell, N.L. Walker, S.M. Cobbe, F.L. Burton, and G.L. Smith The electrophysiological and mechanical effects of 2,3-butane-dione monoxime and cytochalasin-D in the Langendorff perfused rabbit heart Exp Physiol 89 2004 163 172
157. C. Kilkenny, W.J. Browne, I.C. Cuthill, M. Emerson, and D.G. Altman Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research PLoS Biol 8 2010 e1000412
158. R.O. Kingaby, M.J. Lab, A.W. Cole, and T.N. Palmer Relation between monophasic action potential duration, ST segment elevation, and regional myocardial blood flow after coronary occlusion in the pig Cardiovasc Res 20 1986 740 751
159. B. Kloesel, M.J. Ackerman, J. Sprung, B.J. Narr, and T.N. Weingarten Anesthetic management of patients with Brugada syndrome: a case series and literature review Can J Anaesth 58 2011 824 836
160. A. Klumpp, T. Trautmann, M. Markert, and B. Guth Optimizing the experimental environment for dog telemetry studies J Pharmacol Toxicol Methods 54 2006 141 149
161. 2+ release, and catecholaminergic polymorphic ventricular tachycardia J Clin Invest 116 2006 2510 2520
162. D.A. Kroll, and P.R. Knight Antifibrillatory effects of volatile anesthetics in acute occlusion/reperfusion arrhythmias Anesthesiology 61 1984 657 661
163. J. Kuner, V. Enescu, F. Utsu, E. Böszörményi, H. Bernstein, and E. Corday Cardiac arrhythmias during anesthesia Dis Chest 52 1967 580 587
164. S. Kupershmidt, T. Yang, M.E. Anderson, A. Wessels, K.D. Niswender, and M.A. Magnuson Replacement by homologous recombination of the minK gene with lacZ reveals restriction of minK expression to the mouse cardiac conduction system Circ Res 84 1999 146 152
165. M.J. LaPage, and J.P. Saul Update on rhythm mapping and catheter navigation Curr Opin Cardiol 26 2011 79 85
166. D.A. Lathrop Electromechanical characterization of the effects of racemic sotalol and its optical isomers on isolated canine ventricular trabecular muscles and Purkinje strands Can J Physiol Pharmacol 63 1985 1506 1512
167. D.H. Lau, L. Mackenzie, D.J. Kelly, P.J. Psaltis, A.G. Brooks, and M. Worthington Hypertension and atrial fibrillation: evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model Heart Rhythm 7 2010 1282 1290
168. C.L. Lawrence, M.H. Bridgland-Taylor, C.E. Pollard, T.G. Hammond, and J.P. Valentin A rabbit Langendorff heart proarrhythmia model: predictive value for clinical identification of Torsades de Pointes Br J Pharmacol 149 2006 845 860
169. C.L. Lawrence, C.E. Pollard, T.G. Hammond, and J.P. Valentin Nonclinical proarrhythmia models: predicting Torsades de Pointes J Pharmacol Toxicol Methods 52 2005 46 59
170. C.L. Lawrence, C.E. Pollard, T.G. Hammond, and J.P. Valentin In vitro models of proarrhythmia Br J Pharmacol 154 2008 1516 1522
171. J.Y. Le Heuzey, G. Breithardt, J. Camm, H. Crijns, P. Dorian, and P.R. Kowey The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation Am J Cardiol 105 2010 687 693
172. K.W. Lee, Y. Yang, and M.M. Scheinman Atrial flutter: a review of its history, mechanisms, clinical features, and current therapy Curr Probl Cardiol 30 2005 121 167
173. S.E. Lehnart, M.J. Ackerman, D.W. Benson Jr., R. Brugada, C.E. Clancy, and J.K. Donahue Inherited arrhythmias: a National Heart, Lung, and Blood
174. C. Lengyel, A. Varró, K. Tábori, J.G. Papp, and I. Baczkó Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes Br J Pharmacol 151 2007 941 951
175. T. Lewis Report CXIX. Auricular fibrillation: a common clinical condition Br Med J 2 1909 1528
176. T. Lewis Evidences of auricular fibrillation, treated historically Br Med J 1 1912 57 60
177. T. Lewis Observations upon a curious, not uncommon form of extreme acceleration of the auricle: atrial flutter Heart 4 1913 171 182
178. T. Lewis, A.N. Drury, and C.C. Iliescu A demonstration of circus movement in clinical flutter of the auricles Heart 8 1921 341 360
179. T. Lewis, H.S. Feil, and W.D. Stroud Observations upon flutter, fibrillation. Part II, The nature of auricular flutter. Part III, Some effects of rhythmic stimulation of the auricle Heart 7 1920 191 292
180. X. Lian, J. Zhang, S.M. Azarin, K. Zhu, L.B. Hazeltine, and X. Bao Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions Nat Protoc 8 2013 162 175
181. H.E. Lim, H.N. Pak, J.C. Ahn, W.H. Song, and Y.H. Kim Torsade de Pointes induced by short-term oral amiodarone therapy Europace 8 2006 1051 1053
182. T. Liu, B.S. Brown, Y. Wu, C. Antzelevitch, P.R. Kowey, and G.X. Yan Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmias Heart Rhythm 3 2006 948 956
183. G.X. Liu, B.R. Choi, O. Ziv, W. Li, E. de Lange, and Z. Qu Differential conditions for early after-depolarizations and triggered activity in cardiomyocytes derived from transgenic LQT1 and LQT2 rabbits J Physiol 590 2012 1171 1180
184. G. Liu, J.B. Iden, K. Kovithavongs, R. Gulamhusein, H.J. Duff, and K.M. Kavanagh In vivo temporal and spatial distribution of depolarization and repolarization and the illusive murine T wave J Physiol 555 2004 267 279
185. Q. Liu, A.L. Kong, R. Chen, C. Qian, S.W. Liu, and B.G. Sun Propofol and arrhythmias: two sides of the coin Acta Pharmacol Sin 32 2011 817 823
186. D.M. Lloyd-Jones, T.J. Wang, E.P. Leip, M.G. Larson, D. Levy, and R.S. Vasan Lifetime risk for development of atrial fibrillation: the Framingham Heart Study Circulation 110 2004 1042 1046
187. B. London Cardiac arrhythmias: from (transgenic) mice to men J Cardiovasc Electrophysiol 12 2001 1089 1091
188. B. Lown, and M. Wolf Approaches to sudden death from coronary heart disease Circulation 44 1971 130 142
189. H.R. Lu, E. Vlaminckx, and D.J. Gallacher Choice of cardiac tissue in vitro plays an important role in assessing the risk of drug-induced cardiac arrhythmias in human: beyond QT prolongation J Pharmacol Toxicol Methods 57 2008 1 8
190. H.R. Lu, E. Vlaminckx, A. Teisman, and D.J. Gallacher Choice of cardiac tissue plays an important role in the evaluation of drug-induced prolongation of the QT interval in vitro in rabbit J Pharmacol Toxicol Methods 52 2005 90 105
191. H.R. Lu, E. Vlaminckx, A. Van De Water, and D.J. Gallacher Both beta-adrenergic receptor stimulation and cardiac tissue type have important roles in elucidating the functional effects of I(Ks) channel blockers in vitro J Pharmacol Toxicol Methods 51 2005 81 90
192. B.R. Lucchesi, L. Chi, G.S. Friedrichs, S.C. Black, and A.C. Uprichard Antiarrhythmic versus antifibrillatory actions: inference from experimental studies Am J Cardiol 72 1993 25F 44F
193. B.R. Lucchesi, and J.J. Lynch Preclinical assessment of antiarrhythmic drugs Fed Proc 45 1986 2197 2205
194. G.D. Lumb, and L.B. Hardy Collateral circulation and survival related to gradual occlusion of the right coronary artery in the pig Circulation 27 1963 717 721
195. J. MacKenzie New methods of studying affections of the heart. V. The inception of the rhythm of the heart by the ventricle Br Med J 1 1905 812 815
196. B.A. MacLeod, P. Augereau, and M.J. Walker Effects of halothane anesthesia compared with fentanyl anesthesia and no anesthesia during coronary ligation in rats Anesthesiology 58 1983 44 52
197. D. Mainland, L. Herrera, and M.I. Sutcliffe Statistical Tables for Use with Binomial Samples - contingency Tests. Confidence Limits and Sample Size Estimates 1956 University College of Medicine Publications New York
198. G.W. Manning, C.G. McEachern, and G.E. Hall Reflex coronary artery spasm following sudden occlusion of other coronary branches Arch Intern Med 64 1939 661 674
199. R. Mantravadi, B. Gabris, T. Liu, B.R. Choi, W.C. de Groat, and G.A. Ng Autonomic nerve stimulation reverses ventricular repolarization sequence in rabbit hearts Circ Res 100 2007 e72 e80
200. E. Marban Cardiac channelopathies Nature 415 2002 213 218
201. J.B. Martins Neural mechanism initiating and maintaining arrhythmias: summarizing data from animal models and human disease D.P. Zipes, J. Jalife, Cardiac Electrophysiology: From Cell to Bedside 5th ed. 2009 W. B. Saunders Co. Philadelphia 405 413
202. P. Maury, A. Duparc, P. Mondoly, A. Rollin, C. Cardin, and M. Delay Primary electrical diseases diagnosis, genetic and management Minerva Cardioangiol 58 2010 449 483
203. M.P. Maxwell, D.J. Hearse, and D.M. Yellon Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction Cardiovasc Res 21 1987 737 746
204. A. Mazur, D.M. Roden, and M.E. Anderson Systemic administration of calmodulin antagonist W-7 or protein kinase A inhibitor H-8 prevents torsade de pointes in rabbits Circulation 100 1999 2437 2442
205. J.C. McGrath, G.B. Drummond, E.M. McLachlan, C. Kilkenny, and C.L. Wainwright Guidelines for reporting experiments involving animals: the ARRIVE guidelines Br J Pharmacol 160 2010 1573 1576
206. P.L. McLennan, M.Y. Abeywardena, and J.S. Charnock Influence of dietary lipids on arrhythmias and infarction after coronary artery ligation in rats Can J Physiol Pharmacol 63 1985 1411 1417
207. J.A. McWilliam Fibrillar contraction of the heart J Physiol 8 1887 296 310
208. W. Meesman Early arrhythmias and primary ventricular fibrillation after acute myocardial ischaemia in relation to pre-existing coronary collaterals J.R. Parratt, Early arrhythmias resulting from myocardial ischaemia Mechanisms and Prevention by Drugs 1982 Macmillan London 93 112
209. G. Michael, J. Dempster, K.A. Kane, and S.J. Coker Potentiation of E-4031-induced Torsade de Pointes by HMR1556 or ATX-II is not predicted by action potential short-term variability or triangulation Br J Pharmacol 152 2007 1215 1227
210. G. Michael, K.A. Kane, and S.J. Coker Adrenaline reveals the torsadogenic effect of combined blockade of potassium channels in anaesthetized guinea pigs Br J Pharmacol 154 2008 1414 1426
211. D.J. Milan, A.M. Kim, J.R. Winterfield, I.L. Jones, A. Pfeufer, and S. Sanna Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization Circulation 120 2009 553 559
212. P. Milberg, N. Reinsch, N. Osada, K. Wasmer, G. Monnig, and J. Stypmann Verapamil prevents Torsade de Pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3 Basic Res Cardiol 100 2005 365 371
213. G.R. Mines On dynamic equilibrium in the heart J Physiol 46 1913 349 383
214. G.R. Mirams, Y. Cui, A. Sher, M. Fink, J. Cooper, and B.M. Heath Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk Cardiovasc Res 91 2011 53 61
215. G.R. Mirams, M.R. Davies, Y. Cui, P. Kohl, and D. Noble Application of cardiac electrophysiology simulations to pro-arrhythmic safety testing Br J Pharmacol 167 2012 932 945
216. J.S. Mitcheson, J.C. Hancox, and A.J. Levi Cultured adult cardiac myocytes: future applications, culture methods, morphological and electrophysiological properties Cardiovasc Res 39 1998 280 300
217. N.S. Moise Inherited arrhythmias in the dog: potential experimental models of cardiac disease Cardiovasc Res 44 1999 37 46
218. T. Nakagami, H. Tanaka, P. Dai, S.F. Lin, T. Tanabe, and H. Mani Generation of reentrant arrhythmias by dominant-negative inhibition of connexin43 in rat cultured myocyte monolayers Cardiovasc Res 79 2008 70 79
219. National Research Council Nutrient Requirement of Laboratory Animals 4th ed. 1995 National Academy Press Washington D. C
220. National Research Council Guide for the Care and Use of Laboratory Animals 8th ed. 2011 National Academy Press Washington D.C.
221. S. Nattel, G. Duker, and L. Carlsson Model systems for the discovery and development of antiarrhythmic drugs Prog Biophys Mol Biol 98 2008 328 339
222. + channel diversity in the mammalian myocardium J Physiol 525 Pt 2 2000 285 298
223. G.A. Ng, R. Mantravadi, W.H. Walker, W.G. Ortin, B.R. Choi, and W. de Groat Sympathetic nerve stimulation produces spatial heterogeneities of action potential restitution Heart Rhythm 6 2009 696 706
224. D.M. Ninio, K.J. Murphy, P.R. Howe, and D.A. Saint Dietary fish oil protects against stretch-induced vulnerability to atrial fibrillation in a rabbit model J Cardiovasc Electrophysiol 16 2005 1189 1194
225. D.M. Ninio, and D.A. Saint Passive pericardial constraint protects against stretch-induced vulnerability to atrial fibrillation in rabbits Am J Physiol Heart Circ Physiol 291 2006 H2547 H2549
226. D.M. Ninio, and D.A. Saint The role of stretch-activated channels in atrial fibrillation and the impact of intracellular acidosis Prog Biophys Mol Biol 97 2008 401 416
227. K. Nishida, G. Michael, D. Dobrev, and S. Nattel Animal models for atrial fibrillation: clinical insights and scientific opportunities Europace 12 2010 160 172
228. J.E. Nordrehaug, and G. von der Lippe Hypokalaemia and ventricular fibrillation in acute myocardial infarction Br Heart J 50 1983 525 529
229. K. Norton, G. Iacono, and M. Vezina Assessment of the pharmacological effects of inotropic drugs on left ventricular pressure and contractility: an evaluation of the QA interval as an indirect indicator of cardiac inotropism J Pharmacol Toxicol Methods 60 2009 193 197
230. E. Novalija, Q.H. Hogan, A.H. Kulier, L.H. Turner, and Z.J. Bosnjak Effects of desflurane, sevoflurane and halothane on postinfarction spontaneous dysrhythmias in dogs Acta Anaesthesiol Scand 42 1998 353 357
231. D. Nuyens, M. Stengl, S. Dugarmaa, T. Rossenbacker, V. Compernolle, and Y. Rudy Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome Nat Med 7 2001 1021 1027
232. K.E. Odening, M. Kirk, M. Brunner, O. Ziv, P. Lorvidhaya, and G.X. Liu Electrophysiological studies of transgenic long QT type 1 and type 2 rabbits reveal genotype-specific differences in ventricular refractoriness and His conduction Am J Physiol Heart Circ Physiol 299 2010 H643 H655
233. T. Opthof, R. Coronel, and M.J. Janse Is there a significant transmural gradient in repolarization time in the intact heart? Repolarization Gradients in the Intact Heart Circ Arrhythm Electrophysiol 2 2009 89 96
234. T. Opthof, R. Coronel, F.J. Wilms-Schopman, A.N. Plotnikov, I.N. Shlapakova, and P. Danilo Jr. Dispersion of repolarization in canine ventricle and the electrocardiographic T wave: Tp-e interval does not reflect transmural dispersion Heart Rhythm 4 2007 341 348
235. A. Oros, J.D. Beekman, and M.A. Vos The canine model with chronic, complete atrio-ventricular block Pharmacol Ther 119 2008 168 178
236. R. Pabla, and M.J. Curtis Nitric oxide fails to confer endogenous antiarrhythmic cardioprotection in the primate heart in vitro Br J Pharmacol 150 2007 893 898
237. H.M. Park Hypothesis Testing and Statistical Power of a Test Technical Working Paper 2008 The University Information Technology Services (UITS) Center for Statistical and Mathematical Computing, Indiana University (In)
238. J.R. Parratt Early Arrhythmias Resulting from Myocardial Ischaemia. Mechanisms and Prevention by Drugs 1982 Macmillan London
239. J. Parratt, and A. Vegh Pronounced antiarrhythmic effects of ischemic preconditioning Cardioscience 5 1994 9 18
240. C. Patel, and C. Antzelevitch Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome Heart Rhythm 5 2008 585 590
241. R.D. Patten, and M.R. Hall-Porter Small animal models of heart failure: development of novel therapies, past and present Circ Heart Fail 2 2009 138 144
242. R. Pazoki, A.A. Wilde, and C.R. Bezzina Genetic Basis of Ventricular Arrhythmias Curr Cardiovasc Risk Rep 4 2010 454 460
243. K.L. Philp, G. Hart, and S.J. Coker A gender-independent proarrhythmic action of 17beta-estradiol in anaesthetized rabbits Eur J Pharmacol 575 2007 113 121
244. S.M. Pogwizd Nonreentrant mechanisms underlying spontaneous ventricular arrhythmias in a model of nonischemic heart failure in rabbits Circulation 92 1995 1034 1048
245. F. Portaluppi, R. Tiseo, M.H. Smolensky, R.C. Hermida, D.E. Ayala, and F. Fabbian Circadian rhythms and cardiovascular health Sleep Med Rev 16 2012 151 166
246. T. Powell, and V.W. Twist A rapid technique for the isolation and purification of adult cardiac muscle cells having respiratory control and a tolerance to calcium Biochem Biophys Res Commun 72 1976 327 333
247. M.K. Pugsley, S. Authier, and M.J. Curtis Principles of safety pharmacology Br J Pharmacol 154 2008 1382 1399
248. M.K. Pugsley, J.C. Hancox, and M.J. Curtis Perception of validity of clinical and preclinical methods for assessment of Torsades de Pointes liability Pharmacol Ther 119 2008 115 117
249. M.K. Pugsley, R. Towart, S. Authier, D.J. Gallacher, and M.J. Curtis Non-clinical models: validation, study design and statistical consideration in safety pharmacology J Pharmacol Toxicol Methods 62 2010 1 3
250. F. Ravelli, and M. Allessie Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart Circulation 96 1997 1686 1695
251. F. Ravelli, M. Mase, and M. Disertori Mechanical modulation of atrial flutter cycle length Prog Biophys Mol Biol 97 2008 417 434
252. M. Recanatini, A. Cavalli, and M. Masetti Modeling HERG and its interactions with drugs: recent advances in light of current potassium channel simulations ChemMedChem 3 2008 523 535
253. W.S. Redfern, G. Waldron, M.J. Winter, P. Butler, M. Holbrook, and R. Wallis Zebrafish assays as early safety pharmacology screens: paradigm shift or red herring? J Pharmacol Toxicol Methods 58 2008 110 117
254. K blockade as an antiarrhythmic mechanism: effects of UK66,914 on ischaemia and reperfusion arrhythmias in rat and rabbit hearts Br J Pharmacol 108 1993 139 145
255. K1 blockade: a new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit, and primate Circulation 87 1993 1979 1989
256. A.G. Richards, E. Simonson, and M.B. Visscher Electrocardiogram and phonocardiogram of adult and newborn mice in normal conditions and under the effect of cooling, hypoxia, and potassium Am J Physiol 174 1953 293 298
257. D.M. Roden Taking the "idio" out of "idiosyncratic": predicting Torsades de Pointes Pacing Clin Electrophysiol 21 1998 1029 1034
258. S. Rohr, A.G. Kleber, and J.P. Kucera Optical recording of impulse propagation in designer cultures. Cardiac tissue architectures inducing ultra-slow conduction Trends Cardiovasc Med 9 1999 173 179
259. R. Rosen Role of similarity principles in data extrapolation Am J Physiol 244 1983 R591 R599
260. A. Rosenblueth, and J. Garcia Ramos Studies on flutter and fibrillation; the influence of artificial obstacles on experimental auricular flutter Am Heart J 33 1947 677 684
261. C.J. Rothberger, and H. Winterberg Vorhofflimmern und Arhythmia perpetua Wien Klin Wochenschr 22 1909 839 844
262. K. Ryu, J. Sahadevan, C.M. Khrestian, B.S. Stambler, and A.L. Waldo Use of fast fourier transform analysis of atrial electrograms for rapid characterization of atrial activation - implications for delineating possible mechanisms of atrial tachyarrhythmias J Cardiovasc Electrophysiol 17 2006 198 206
263. I.N. Sabir, M.J. Killeen, A.A. Grace, and C.L. Huang Ventricular arrhythmogenesis: insights from murine models Prog Biophys Mol Biol 98 2008 208 218
264. M.C. Sanguinetti, and P.B. Bennett Antiarrhythmic drug target choices and screening Circ Res 93 2003 491 499
265. F. Sarmast, A. Kolli, A. Zaitsev, K. Parisian, A.S. Dhamoon, and P.K. Guha Cholinergic atrial fibrillation: I(K, ACh) gradients determine unequal left/right atrial frequencies and rotor dynamics Cardiovasc Res 59 2003 863 873
266. M.M. Scheinman Catheter techniques for ablation of supraventricular tachycardia N Engl J Med 320 1989 460 461
267. M.M. Scheinman, and Y. Yang Atrial flutter: historical notes - part 1 Pacing Clin Electrophysiol 27 2004 379 381
268. U. Schotten, S. Verheule, P. Kirchhof, and A. Goette Pathophysiological mechanisms of atrial fibrillation: a translational appraisal Physiol Rev 91 2011 265 325
269. E.H. Schuster, and B.H. Bulkley Ischemia at a distance after acute myocardial infarction: a cause of early postinfarction angina Circulation 62 1980 509 515
270. P.J. Schwartz Do animal models have clinical value? Am J Cardiol 81 1998 14D 20D
271. P.J. Schwartz, and D.P. Zipes Autonomic modulation of cardiac arrhythmias D.P. Zipes, J. Jalife, Cardiac Electrophysiology: From Cell to Bedside 3rd ed. 2000 W. B. Saunders Co. Philadelphia 300 314
272. K. Seo, M. Inagaki, S. Nishimura, I. Hidaka, M. Sugimachi, and T. Hisada Structural heterogeneity in the ventricular wall plays a significant role in the initiation of stretch-induced arrhythmias in perfused rabbit right ventricular tissues and whole heart preparations Circ Res 106 2010 176 184
273. R.R. Shah, and L.M. Hondeghem Refining detection of drug-induced proarrhythmia: QT interval and TRIaD Heart Rhythm 2 2005 758 772
274. O.F. Sharifov, V.V. Fedorov, G.G. Beloshapko, A.V. Glukhov, A.V. Yushmanova, and L.V. Rosenshtraukh Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs J Am Coll Cardiol 43 2004 483 490
275. K. Shiki, and D.J. Hearse Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias Am J Physiol 253 1987 H1470 H1476
276. W. Shimizu, and C. Antzelevitch Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome Circulation 96 1997 2038 2047
277. W. Shimizu, and C. Antzelevitch Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and Torsade de Pointes Circulation 98 1998 2314 2322
278. J.S. Shinbane, M.A. Wood, D.N. Jensen, K.A. Ellenbogen, A.P. Fitzpatrick, and M.M. Scheinman Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies J Am Coll Cardiol 29 1997 709 715
279. M.E. Silverman From rebellious palpitations to the discovery of auricular fibrillation: contributions of Mackenzie, Lewis and Einthoven Am J Cardiol 73 1994 384 389
280. J.E. Skinner, J.T. Lie, and M.L. Entman Modification of ventricular fibrillation latency following coronary artery occlusion in the conscious pig Circulation 51 1975 656 667
281. + currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium J Am Coll Cardiol 55 2010 2330 2342
282. C.L. Stables, and M.J. Curtis Development and characterization of a mouse in vitro model of ischaemia-induced ventricular fibrillation Cardiovasc Res 83 2009 397 404
283. P.J. Stansfeld, P. Gedeck, M. Gosling, B. Cox, J.S. Mitcheson, and M.J. Sutcliffe Drug block of the hERG potassium channel: insight from modeling Proteins 68 2007 568 580
284. P. Taggart, P. Sutton, T. Opthof, R. Coronel, and P. Kallis Electrotonic cancellation of transmural electrical gradients in the left ventricle in man Prog Biophys Mol Biol 82 2003 243 254
285. J. Tamargo, R. Caballero, L. Nunez, R. Gomez, M. Vaquero, and E. Delpon Genetically engineered mice as a model for studying cardiac arrhythmias Front Biosci 12 2007 22 38
286. H. Tashibu, H. Miyazaki, K. Aoki, Y. Akie, and K. Yamamoto QT PRODACT: in vivo QT assay in anesthetized dog for detecting the potential for QT interval prolongation by human pharmaceuticals J Pharmacol Sci 99 2005 473 486
287. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart rate variability: standards of measurement, physiological interpretation and clinical use Circulation 93 1996 1043 1065
288. The Jackson Laboratory Breeding Strategies for Maintaining Colonies of Laboratory Mice 2009 Jackson Laboratory Resource Manual
289. M.B. Thomsen, J. Matz, P.G. Volders, and M.A. Vos Assessing the proarrhythmic potential of drugs: current status of models and surrogate parameters of torsades de pointes arrhythmias Pharmacol Ther 112 2006 150 170
290. M.B. Thomsen, S.C. Verduyn, M. Stengl, J.D. Beekman, G. de Pater, and J. van Opstal Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs Circulation 110 2004 2453 2459
291. 2+-calmodulin mediated modulation of the electrical coupling of ventricular myocytes isolated from guinea pig heart J Mol Cell Cardiol 26 1994 1007 1015
292. Y. Trolese-Mongheal, P. Duchene-Marullaz, J.F. Trolese, M. Leinot, J.C. Lamar, and P. Lacroix Sudden death and experimental acute myocardial infarction Am J Cardiol 56 1985 677 681
293. K. Tsuchihashi, and M.J. Curtis Influence of tedisamil on the initiation and maintenance of ventricular fibrillation: chemical defibrillation by Ito blockade? J Cardiovasc Pharmacol 18 1991 445 456
294. J. Tuan, M. Jeilan, S. Kundu, W. Nicolson, I. Chung, and P.J. Stafford Regional fractionation and dominant frequency in persistent atrial fibrillation: effects of left atrial ablation and evidence of spatial relationship Europace 13 2011 1550 1556
295. J.P. Valentin, P. Hoffmann, F. De Clerck, T.G. Hammond, and L. Hondeghem Review of the predictive value of the Langendorff heart model (Screenit system) in assessing the proarrhythmic potential of drugs J Pharmacol Toxicol Methods 49 2004 171 181
296. H.J. van der Linde, B. Van Deuren, Y. Somers, B. Loenders, R. Towart, and D.J. Gallacher The Electro-Mechanical window: a risk marker for Torsade de Pointes in a canine model of drug induced arrhythmias Br J Pharmacol 161 2010 1444 1454
297. Ks in dog ventricular muscle and Purkinje fibre repolarization J Physiol 523 Pt 1 2000 67 81
298. M.W. Veldkamp, A.O. Verkerk, A.C. van Ginneken, A. Baartscheer, C. Schumacher, and N. de Jonge Norepinephrine induces action potential prolongation and early afterdepolarizations in ventricular myocytes isolated from human end-stage failing hearts Eur Heart J 22 2001 955 963
299. J.T. Vermeulen, M.A. McGuire, T. Opthof, R. Coronel, J.M. de Bakker, and C. Klopping Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts Cardiovasc Res 28 1994 1547 1554
300. 1-adrenoceptor-stimulated rabbits Br J Pharmacol 153 2008 75 89
301. A. Volpi, A. Cavalli, E. Santoro, and G. Tognoni Incidence and prognosis of secondary ventricular fibrillation in acute myocardial infarction. Evidence for a protective effect of thrombolytic therapy. GISSI Investigators Circulation 82 1990 1279 1288
302. D. von Lewinski, E. Bisping, A. Elgner, J. Kockskamper, and B. Pieske Mechanistic insight into the functional and toxic effects of Strophanthidin in the failing human myocardium Eur J Heart Fail 9 2007 1086 1094
303. M.A. Vos, S.C. Verduyn, A.P. Gorgels, G.C. Lipcsei, and H.J. Wellens Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block Circulation 91 1995 864 872
304. F. Voss, K.D. Schreiner, J.C. Senges, R. Becker, A. Bauer, and W. Kuebler Refractory patterns and susceptibility to drug-induced polymorphic ventricular tachycardias in dogs with chronic atrioventricular block: relation to the type of anesthesia J Cardiovasc Pharmacol 40 2002 651 659
305. A.L. Waldo Mechanisms of atrial fibrillation, atrial flutter, and ectopic atrial tachycardia - a brief review Circulation 75 1987 III37 III40
306. M.J. Walker, M.J. Curtis, D.J. Hearse, R.W. Campbell, M.J. Janse, and D.M. Yellon The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion Cardiovasc Res 22 1988 447 455
307. S. Wallenstein, C.L. Zucker, and J.L. Fleiss Some statistical methods useful in circulation research Circ Res 47 1980 1 9
308. D. Wang, C. Patel, C. Cui, and G.X. Yan Preclinical assessment of drug-induced proarrhythmias: role of the arterially perfused rabbit left ventricular wedge preparation Pharmacol Ther 119 2008 141 151
309. J. Weissenburger, J.M. Davy, F. Chezalviel, O. Ertzbischoff, J.M. Poirier, and F. Engel Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol J Pharmacol Exp Ther 259 1991 871 883
310. J. Weissenburger, V.V. Nesterenko, and C. Antzelevitch Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in vivo: Torsades de Pointes develops with halothane but not pentobarbital anesthesia J Cardiovasc Electrophysiol 11 2000 290 304
311. 2+ exchange and cell contraction in isolated neonatal and adult rabbit cardiac myocytes Am J Physiol 268 1995 H1723 H1733
312. M.C. Wijffels, C.J. Kirchhof, R. Dorland, and M.A. Allessie Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats Circulation 92 1995 1954 1968
313. B.J. Winer Statistical Principles in Experimental Design 1962 McGraw Hill New York
314. A.L. Wit, and M.J. Janse Experimental models of ventricular tachycardia and fibrillation caused by ischemia and infarction Circulation 85 1992 I32 I42
315. H.J. Witchel Emerging trends in ion channel-based assays for predicting the cardiac safety of drugs IDrugs 13 2010 90 96
316. D. Xu, N. Murakoshi, M. Igarashi, A. Hirayama, Y. Ito, and Y. Seo PPAR-gamma activator pioglitazone prevents age-related atrial fibrillation susceptibility by improving antioxidant capacity and reducing apoptosis in a rat model J Cardiovasc Electrophysiol 23 2012 209 217
317. D. Xu, N. Murakoshi, H. Tada, M. Igarashi, Y. Sekiguchi, and K. Aonuma Age-related increase in atrial fibrillation induced by transvenous catheter-based atrial burst pacing: an in vivo rat model of inducible atrial fibrillation J Cardiovasc Electrophysiol 21 2010 88 93
318. K. Yamamoto, T. Tamura, R. Imai, and M. Yamamoto Acute canine model for drug-induced Torsades de Pointes in drug safety evaluation - influences of anesthesia and validation with quinidine and astemizole Toxicol Sci 60 2001 165 176
319. G.X. Yan, and C. Antzelevitch Cellular basis for the electrocardiographic J wave Circulation 93 1996 372 379
320. G.X. Yan, Y. Wu, T. Liu, J. Wang, R.A. Marinchak, and P.R. Kowey Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome: direct evidence from intracellular recordings in the intact left ventricular wall Circulation 103 2001 2851 2856
321. Y.G. Yap, and A.J. Camm Drug induced QT prolongation and torsades de pointes Heart 89 2003 1363 1372
322. L. Yue, P. Melnyk, R. Gaspo, Z. Wang, and S. Nattel Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation Circ Res 84 1999 776 784
323. W. Zareba Drug induced QT prolongation Cardiol J 14 2007 523 533
324. J. Zhuang, K.A. Yamada, J.E. Saffitz, and A.G. Kleber Pulsatile stretch remodels cell-to-cell communication in cultured myocytes Circ Res 87 2000 316 322
325. D.P. Zipes, A.J. Camm, M. Borggrefe, A.E. Buxton, B. Chaitman, and M. Fromer ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Eur Heart J 27 2006 2099 2140
326. O. Ziv, E. Morales, Y.K. Song, X. Peng, K.E. Odening, and A.E. Buxton Origin of complex behaviour of spatially discordant alternans in a transgenic rabbit model of type 2 long QT syndrome J Physiol 587 2009 4661 4680
327. M. Zorniak, K. Mitrega, S. Bialka, M. Porc, and T.F. Krzeminski Comparison of thiopental, urethane, and pentobarbital in the study of experimental cardiology in rats in vivo J Cardiovasc Pharmacol 56 2010 38 44